Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 23;216(2):132-145.
doi: 10.1093/cei/uxae016.

Altered CD226/TIGIT expressions were associated with NK phenotypes in primary antiphospholipid syndrome and affected by IL-4/JAK pathway

Yan Long  1 , Ke-Jia Lu  1   2 , Chang-Sheng Xia  1 , Jing-Hong Feng  1 , Wen-Yi Li  1 , Yin-Ting Ma  1 , Yuan-Yuan Sun  1 , Chun-Hong Fan  1 , Chun Li  3
Affiliations

Altered CD226/TIGIT expressions were associated with NK phenotypes in primary antiphospholipid syndrome and affected by IL-4/JAK pathway

Yan Long et al. Clin Exp Immunol. .

Abstract

Natural killer (NK) cells were reported to be involved in the pathogenesis of primary antiphospholipid syndrome (pAPS). Immunosuppressive receptor T-cell immunoreceptor with Ig and ITIM domains (TIGIT) and activating receptor cluster of differentiation 226 (CD226) are specifically expressed on NK cells with competitive functions. This study aims to investigate the expression diversities of CD226/TIGIT on NK subsets and their associations with NK subsets activation phenotypes and potential clinical significance, furthermore, to explore potential cause for CD226/TIGIT expression diversities in pAPS. We comparatively assessed the changes of CD56brightNK, CD56dimNK, and NK-like cells in 70 pAPS patients compared with control groups, including systemic lupus erythematosus, asymptomatic antiphospholipid antibodies carriers (asymp-aPLs carriers), and healthy controls and their expression diversities of CD226/TIGIT by flow cytometry. CD25, CD69, CD107α expression, and interferon gamma (IFN-γ) secretion levels of NK subsets were detected to determine the potential association of CD226/TIGIT expression with NK subsets phenotypes. CD226/TIGIT expression levels were compared among different subgroups divided by aPLs status. Moreover, in vitro cultures were conducted to explore the potential mechanisms of CD226/TIGIT expression imbalance. CD56brightNK and CD3+CD56+NK-like cells were significantly increased while CD56dimNK cells were obviously decreased in pAPS, and CD56brightNK and NK-like cells exhibited significantly higher CD226 but lower TIGIT expressions. CD226+CD56brightNK and TIGIT-CD56brightNK cells show higher CD69 expression and IFN-γ secretion capacity, and CD226+NK-like and TIGIT-NK-like cells showed higher expressions of CD25 and CD69 but lower apoptosis rate than CD226- and TIGIT+CD56brightNK/NK-like cells, respectively. The imbalanced CD226/TIGIT expressions were most significant in aPLs triple-positive group. Imbalanced expressions of CD226/TIGIT on CD56brightNK and NK-like cells were aggravated after interleukin-4 (IL-4) stimulation and recovered after tofacitinib blocking. Our data revealed significant imbalanced CD226/TIGIT expressions on NK subsets in pAPS, which closely associated with NK subsets phenotypes and more complicated autoantibody status. CD226/TIGIT imbalanced may be affected by IL-4/Janus Kinase (JAK) pathway activation.

Keywords: CD226; IL-4; JAK; T-cell immunoreceptor with Ig and ITIM domains; natural killer cell; natural killer-like cell; primary antiphospholipid syndrome.

PubMed Disclaimer

Conflict of interest statement

None declared.

Similar articles

See all similar articles

References

    1. Oliveira DC, Correia A, Oliveira C.. The issue of the antiphospholipid antibody syndrome. J Clin Med Res 2020, 12, 286–92. doi:10.14740/jocmr4154 - DOI - PMC - PubMed
    1. Kuwana M. Autoreactive CD4(+) T cells to beta(2)-glycoprotein I in patients with antiphospholipid syndrome. Autoimmun Rev 2003, 2, 192–8. doi:10.1016/s1568-9972(03)00007-7 - DOI - PubMed
    1. Karakantza M, Theodorou GL, Meimaris N, Mouzaki A, John E, Andonopoulos AP, et al.Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome. Ann Hematol 2004, 83, 704–11. doi:10.1007/s00277-004-0910-7 - DOI - PubMed
    1. Noureldine MHA, Nour-Eldine W, Khamashta MA, Uthman I.. Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome. Semin Arthritis Rheum 2019, 48, 860–6. doi:10.1016/j.semarthrit.2018.08.004 - DOI - PubMed
    1. Chalan P, Bijzet J, Kroesen BJ, Boots AM, Brouwer E.. Altered natural killer cell subsets in seropositive arthralgia and early rheumatoid arthritis are associated with autoantibody status. J Rheumatol 2016, 43, 1008–16. doi:10.3899/jrheum.150644 - DOI - PubMed